Immaculate Ampeire

Kampala, C, Uganda

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Community-Led Defaulter Tracking for Catch-Up Vaccination: Implementation Experience in Uganda, 2022 and 2024.

Community-Led Defaulter Tracking for Catch-Up Vaccination: Implementation Experience in Uganda, 2022 and 2024.

Journal: Vaccines

Published: April 16, 2026

Emergence of measles virus genotype D8 amidst endemic B3 circulation in Uganda, 2023-2025.

Emergence of measles virus genotype D8 amidst endemic B3 circulation in Uganda, 2023-2025.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: October 02, 2025

Policies and strategies for HPV vaccination schedule completion in immunocompromised girls, including girls living with HIV: Qualitative insights from Eswatini, Malawi, and Uganda.

Policies and strategies for HPV vaccination schedule completion in immunocompromised girls, including girls living with HIV: Qualitative insights from Eswatini, Malawi, and Uganda.

Journal: PLOS global public health

Published: May 08, 2025

Effect of 10-valent pneumococcal conjugate vaccine on trends of pneumococcal meningitis in children under five years, Uganda, 2003-2022.

Effect of 10-valent pneumococcal conjugate vaccine on trends of pneumococcal meningitis in children under five years, Uganda, 2003-2022.

Journal: BMC infectious diseases

Published: August 14, 2024

Safety of nOPV2 administered during a supplementary immunisation activity in Uganda, 2022: data triangulation from a prospective cohort event monitoring programme and vaccine safety surveillance reports.

Safety of nOPV2 administered during a supplementary immunisation activity in Uganda, 2022: data triangulation from a prospective cohort event monitoring programme and vaccine safety surveillance reports.

Journal: The Lancet. Global health

Published: June 12, 2024

The road to a polio-free Uganda; contribution of the Expanded Program on Immunization Laboratory (EPI-LAB) at Uganda Virus Research Institute.

The road to a polio-free Uganda; contribution of the Expanded Program on Immunization Laboratory (EPI-LAB) at Uganda Virus Research Institute.

Journal: African health sciences

Published: February 15, 2024

Cost and operational context for national human papillomavirus (HPV) vaccine delivery in six low- and middle-income countries.

Cost and operational context for national human papillomavirus (HPV) vaccine delivery in six low- and middle-income countries.

Journal: Vaccine

Published: October 04, 2023

Viruses associated with measles-like illnesses in Uganda.

Viruses associated with measles-like illnesses in Uganda.

Journal: The Journal of infection

Published: August 26, 2023

Engagement of community health workers to improve immunization coverage through addressing inequities and enhancing data quality and use is a feasible and effective approach: An implementation study in Uganda.

Engagement of community health workers to improve immunization coverage through addressing inequities and enhancing data quality and use is a feasible and effective approach: An implementation study in Uganda.

Journal: PloS one

Published: May 03, 2023

Environmental surveillance detects circulating vaccine-derived poliovirus type 2 that was undetected by acute flaccid paralysis surveillance in 2021 in Uganda.

Environmental surveillance detects circulating vaccine-derived poliovirus type 2 that was undetected by acute flaccid paralysis surveillance in 2021 in Uganda.

Journal: Archives of virology

Published: January 10, 2023

Development of a Scorecard to Monitor Progress toward National Cholera Elimination: Its Application in Uganda.

Development of a Scorecard to Monitor Progress toward National Cholera Elimination: Its Application in Uganda.

Journal: The American journal of tropical medicine and hygiene

Published: January 03, 2023

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.

Journal: The Lancet. Infectious diseases

Published: November 07, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026